Michael A. Metzger, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 30,118 shares at $21.07 ($635K) on 2022-07-06, disclosed to the SEC on 2022-07-08.
Open-market sale of $635k SNDX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.07 | 15,009 | $316K | 49.8% |
| 2 | $21.07 | 15,009 | $316K | 49.8% |
| 3 | $21.00 | 100 | $2K | 0.3% |
| Total | $21.07 avg | 30,118 | $635K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |